Cardiology Research Review: Issue 156, with commentary by A/Prof John Amerena

In this issue:

Self-administered intranasal etripamil for paroxysmal SVT
Vitamin D supplementation does not have cardioprotective effects
Barriers to prescribing PCSK9 inhibitors after coronary revascularisation
Ferric carboxymaltose in patients with HF and iron deficiency
Semaglutide in patients with obesity-related HFpEF
Are anticoagulants justified in patients with atrial high-rate episodes?
Should frail elderly patients who are taking warfarin be switched to a NOAC?
Phase 1 trial of muvalaplin, an oral small molecule inhibitor of lipoprotein(a) formation
Catheter ablation vs medical therapy for AF in end-stage HF
Multivessel immediate vs staged revascularisation in acute STEMI